Susquehanna International »

Revance Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.9M 425k 11.47
2023-06-30 $9.0M 355k 25.31
2023-03-31 $14M 418k 32.21
2022-12-31 $18M 972k 18.46
2022-09-30 $14M 532k 27.00
2022-06-30 $4.6M 336k 13.82
2022-03-31 $10M 524k 19.50
2021-12-31 $3.3M 203k 16.32
2021-09-30 $5.6M 201k 27.86
2021-06-30 $5.4M 181k 29.64
2021-03-31 $7.5M 268k 27.95
2020-12-31 $6.7M 237k 28.34
2020-09-30 $5.7M 225k 25.15
2020-06-30 $4.2M 172k 24.42
2020-03-31 $2.4M 165k 14.80
2019-12-31 $3.1M 192k 16.23
2019-09-30 $2.5M 194k 13.00
2019-06-30 $2.0M 157k 12.98
2019-03-31 $1.1M 69k 15.76
2018-12-31 $310k 15k 20.13
2018-09-30 $2.0M 82k 24.86
2018-06-30 $2.2M 81k 27.45
2018-03-31 $2.7M 88k 30.83
2017-12-31 $11M 318k 35.75
2017-09-30 $3.0M 107k 27.55
2017-06-30 $1.2M 46k 26.39
2017-03-31 $737k 36k 20.77
2016-12-31 $656k 32k 20.68
2016-09-30 $170k 11k 16.19
2016-06-30 $431k 32k 13.61
2016-03-31 $1.7M 99k 17.47
2015-12-31 $7.0M 204k 34.16
2015-09-30 $3.0M 102k 29.75
2015-06-30 $1.2M 38k 31.98
2015-03-31 $896k 43k 20.75
2014-06-30 $351k 10k 33.98